|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Impairment of acquired contract intangible asset | |||||
| Share-based compensation expense | |||||
| Gain on sale of business | |||||
| Amortization of premiums and discounts on short-term investments, net | |||||
| Non-cash interest expense | |||||
| Non-cash lease expense | |||||
| Depreciation and amortization expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Operating lease liabilities, net | |||||
| Accounts payable and accrued liabilities | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Proceeds from sale of business, net cash, cash equivalents, and restricted cash | |||||
| Purchases of property and equipment | |||||
| Purchases of short-term investments | |||||
| Maturities of short-term investments | |||||
| Net cash provided by investing activities | |||||
| Financing activities: | |||||
| Proceeds from issuance of common stock and prefunded warrants to PIPE Investors | |||||
| Proceeds from sale of common stock and prefunded warrants in PIPE financing | |||||
| Payment of PIPE financing related transaction costs | |||||
| Issuance of common stock upon exercise of stock options | |||||
| Proceeds from issuance under employee stock purchase plan | |||||
| Issuance of common stock upon exercise of warrants | |||||
| Deferred offering costs paid for financing | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid during the period | |||||
| Costs incurred in connection with issuance of common stock paid during the period | |||||
| Supplemental disclosure of non-cash activities: | |||||
| Deferred transaction costs included in accounts payable and accrued liabilities | |||||
| Amounts accrued for purchases of property and equipment | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
Loading...